Clinical trial
A Multicentre Feasibility Study of Online Adaptive Image Guided Radiotherapy for Muscle Invasive Bladder Cancer
NCT01142102 is registered in ClinicalTrials.gov with Trans Tasman Radiation Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre Feasibility Study of Online Adaptive Image Guided Radiotherapy for Muscle Invasive Bladder Cancer
- Lead sponsor
- Trans Tasman Radiation Oncology Group
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- June 30, 2015
- Enrollment
- 50 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer